TrialBritish journal of haematology2015

Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study.

Peter M Voorhees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.